Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Blood 30. July 2026
Search
medline.ch
Blood
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8469  Previews Next
   
   Articles 1 - 20 / 169376  
   
Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.
Ann Hematol
Mueller S, Pan CC, Bosák J, Hofmann J, Losch FO, Wilke T, Deiters B, .
PMID: 42530652 [PubMed - indexed for MEDLINE]


Allogeneic stem cell transplantation for mantle cell lymphoma can achieve durable remission and myeloablative conditioning is associated with inferior survival: an Australian and New Zealand Transplant & Cellular Therapies registry study.
Intern Med J
McKeague S, Di Ciaccio PR, Tran S, Minson A, Richie D, Kennedy G, Milliken S, Purtill D, Gottlieb D, Perera T, Yeung DT, Larsen SR, Doocey R, Greenwood M, Durrant S, Watson AM, Butler A, Khot A, Curley C, Hamad N.
PMID: 42529922 [PubMed - as supplied by publisher]


Persistent racial and socioeconomic inequities in mycosis fungoides survival: a population-based study.
Front Public Health
Zhang T, Du S, Xue W, Wang Z, Idris OA, Bunton-Young CR.
PMID: 42528961 [PubMed - indexed for MEDLINE]


Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia.
Front Immunol
Wang Y, Yu T, Wang M, Yu L.
PMID: 42528842 [PubMed - indexed for MEDLINE]


Imaging predictors of response and outcomes after CAR T-cell therapy in lymphoma: from clinical trials to real-world practice.
Front Immunol
Yi W, Lee HJ, Kim N, Na S, Pallod S, Cho H, Yoon DH, Kim KW.
PMID: 42528814 [PubMed - indexed for MEDLINE]


Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman.
Front Oncol
Al-Rawahi N, Salman B, Meenakshi DU, Al-Khabori M, Al-Hanini M, Al-Kindi S.
PMID: 42528802 [PubMed]


The impact of pretransplant consolidation chemotherapy on clinical outcomes in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a single-center retrospective study.
Front Oncol
Sun J, Sun Q, Kang Z, Yang Y, Xie F, Ma L, Yan J.
PMID: 42528749 [PubMed]


Chronic lymphocytic leukemia management in India: balancing evidence, access, and affordability in clinical practice.
Front Oncol
Sahni S, Rani L, Gupta R, Gogia A.
PMID: 42528663 [PubMed]


A case of bone marrow-liver-spleen type diffuse large B-cell lymphoma: importance of rapid diagnosis and therapeutic intervention.
J Clin Exp Hematop
Eda H, Furihata K, Ogasawara F.
PMID: 42528232 [PubMed - as supplied by publisher]


Real-world comparison of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone and anthracycline-based regimens in peripheral T-cell lymphoma: A multicenter retrospective study from the Gifu Hematology Study Group.
J Clin Exp Hematop
Nakamura N, Kanemura N, Hayase N, Kaneda Y, Ikoma Y, Goto T, Suzaki T, Kitagawa J, Kasahara S, Yamada T, Sawada M, Fukuno K, Takada E, Goto H, Lee S, Fujita K, Morishita T, Hara T, Tsurumi H, Shimizu M.
PMID: 42528231 [PubMed - as supplied by publisher]


Efficacy and Safety of Tyrosine Kinase Inhibitor Combined With Venetoclax-Based Regimen in Pediatric Patients With Chronic Myeloid Leukemia in the Blast Phase: A Single-Center Retrospective Study.
Pediatr Blood Cancer
Zheng F, Zhang L, Ding M, Lu A, Jia Y, Zeng H, Zhang L.
PMID: 42528004 [PubMed - as supplied by publisher]


Follicular Lymphoma: Novel Therapies and Strategies for Optimal Therapeutic Sequencing.
Curr Oncol Rep
Fonseca R, Hilal T.
PMID: 42527721 [PubMed - indexed for MEDLINE]


Invasive mold infection in pediatric acute lymphoblastic leukemia-a detailed analysis of the clinical trial AIEOP-BFM ALL2009.
Leukemia
Lehrnbecher T, Cesaro S, Alten J, Attarbaschi A, Barbaric D, Bochennek K, Bodmer N, Conter V, Elitzur S, Möricke A, Schrappe M, Stary J, Zapotocka E, Zimmermann M, Groll AH.
PMID: 42527667 [PubMed - as supplied by publisher]


Dose Optimization of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis of 50 mg Versus 100 mg Once Daily.
Clin Lymphoma Myeloma Leuk
Abdulgayoom M, Almahmood M, Kaddoura R, Mesilhy R, Ahmad R, Afana MS, Dalol AA, Alshurafa A, Al-Mashdali AF, Yassin M, Mohamed SF.
PMID: 42527251 [PubMed - as supplied by publisher]


Leucovorin Versus Levoleucovorin Rescue After High-dose Methotrexate in Central Nervous System Lymphoma.
Anticancer Res
Nakashima T, Imai Y, Asano T, Hashimoto H.
PMID: 42527076 [PubMed - indexed for MEDLINE]


Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826).
Blood Adv
Ahmed S, Li H, Herrera AF, Perry AM, Kovach AE, Rutherford SC, Davison K, Castellino SM, Evens AM, Kahl BS, Bartlett N, Leonard JP, Shipp MA, Smith SM, Kelly KM, LeBlanc ML, Friedberg JW, Song JYY.
PMID: 42526889 [PubMed - as supplied by publisher]


Molecular Subtypes and Genetic Diagnostics in B-cell Acute Lymphoblastic Leukemia.
Hum Pathol
Azevedo RS, Medeiros LJ, Loghavi S, Short NJ.
PMID: 42526647 [PubMed - as supplied by publisher]


Distinguishing EBV-positive classic Hodgkin lymphoma from EBV-positive DLBCL, NOS: diagnostic value and limits of immunohistochemical markers.
Ann Diagn Pathol
Johanna V, Francesca VL, Lukas M, Jonas VH, Lucienne M, Louis K, Xenia H, Leandro B, Peter V, Xavier S, Daan D, Thomas T.
PMID: 42526361 [PubMed - as supplied by publisher]


Prediction of Lymphoma Bone Marrow Infiltration by Machine Learning Models Based on Fluorine-18 Fluorodeoxyglucose Positron Emission Computed Tomography.
JCO Glob Oncol
Zhang Z, Yang T, Liu D, Sa R, Guan F.
PMID: 42525912 [PubMed - indexed for MEDLINE]


Outcomes of Adults Age 40 Years and Older With Newly Diagnosed ALL: A Multicenter Registry Analysis From the Hematology Cancer Consortium.
JCO Glob Oncol
Jain P, Jain H, Sarma RJ, Kulkarni U, Karunakaran P, Kayal S, Ganesan P, Lk R, Damodar S, Kapoor R, Palassery R, Krishnan U, Roshan R, Chozakade A, Asokan A, Samuel P, Karunamurthy O, Mathews V, Sengar M.
PMID: 42525909 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 169376    Page 1 of 8469  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1